4th European CAR T-cell Meeting
The European Hematology Association (EHA) and the EBMT recently hosted the 4th edition of the jointly organized European CAR T-cell Meeting.
Dates: February 10-12, 2022
Chairs: Michael Hudecek & Ibrahim Yakoub-Agha
Scientific sessions were recorded, watch them on-demand via the meeting platform.
Please note that registration is closed. Only parties registered in time for the live meeting days have the opportunity to watch on-demand content. The platform is open until March 12, 2022 (23:59 CET).
EHA Topics-in-Focus Immunotherapy
This meeting is part of the EHA Topics-in-Focus (TIF) program on Immunotherapy, aimed at raising awareness, providing education, furthering research, and building a network of experts to improve patient care. Further information, including a link to the brand-new website dedicated to Immunotherapy, please see our website.
Due to the ongoing pandemic and varying travel restrictions this meeting has been converted from hybrid to fully virtual. All sessions were livestreamed and the recordings can be accessed by registered delegates on the virtual platform.
The target audience is hematologists, oncologists, physicians, nurses, data managers, supply chain managers, patients or patient organization representatives, biotech representatives, pharmacists and manufacturers.
The meeting covered a broad range of topics including deep science and translational, clinical and commercial development in the field of CAR T. The program brought you all the latest in CAR T and the first ever reported clinical data. The program further covered various CAR T-Cell related topics and includes key note lectures, interactive debate sessions and more.
To view the program , see the meeting program page.
Scientific Program Committee
The Scientific Program Committee (SPC) have created the program and helped to select speakers. The members are:
Abstract submission is an important part of this meeting. Participants had the opportunity to submit an abstract for this meeting, and (if accepted) had the possibility to discuss it with the international faculty and peers.
Introduced last year, we were excited to announce 2nd Emerging Investigators EHA-EBMT Joint Fellowship Awards in the Field of Cell Therapy and Immunotherapy 2022. Submitters could apply for this award and the Scientific Program Committee selected 3 winners. Check who the winners were by viewing the Award session on the platform.
Registration is closed as of February 12, 2022.
This meeting is supported by:
Supreme Level Partner
Major Level Partner
EBAH CME accreditation
This meeting is accredited by the European Board for Accreditation in Hematology (EBAH) CME. EBAH CME is the best way for hematologists to master the latest developments within the specialty of hematology. Staying abreast of these scientific developments and keeping in touch with the up-to-date views on clinical policy will enable you to raise your professional level, ultimately resulting in the best treatment for your patients.